Aripiprazole Lauroxil

CAT#: H326728

CAS#:

Description: Aripiprazole lauroxil, aslo known as RDC 3317, is a long-acting injectable atypical antipsychotic. It is an N-acyloxymethyl prodrug of aripiprazole that is administered via intramuscular injection once every four to six weeks for the treatment of schizophrenia. Aripiprazole lauroxil was approved by the U.S. FDA on 5 October 2015.

img

Synthetic Routes

Aripiprazole Lauroxil - Synthetic Route 1

Aripiprazole Lauroxil route01

Synthetic reference

Aripiprazole Lauroxil - Synthetic Route 2

Aripiprazole Lauroxil route02

Synthetic reference

Aripiprazole Lauroxil - Synthetic Route 3

Aripiprazole Lauroxil route03

Synthetic reference

Aripiprazole Lauroxil - Synthetic Route 4

Aripiprazole Lauroxil route04

Synthetic reference

Aripiprazole Lauroxil - Synthetic Route 5

Aripiprazole Lauroxil route05

Synthetic reference

Aripiprazole Lauroxil - Synthetic Route 6

Aripiprazole Lauroxil route06

Synthetic reference

Aripiprazole Lauroxil - Synthetic Route 7

Aripiprazole Lauroxil route07

Synthetic reference

Aripiprazole Lauroxil - Synthetic Route 8

Aripiprazole Lauroxil route08

Synthetic reference

Anon. A process for the preparation of aripiprazole lauroxil. IP.com Journal. Volume 18. Issue 8A. Pages 1-2. 2018.

Aripiprazole Lauroxil - Synthetic Route 9

Aripiprazole Lauroxil route09

Synthetic reference

Hsiao, Tsung-Yu; Huang, Yu-Hui. Process for preparing aripiprazole lauroxil and intermediates thereof from aripiprazole. Assignee Scinopharm Taiwan, Ltd., Taiwan. US 20180265472. 2018.

Aripiprazole Lauroxil - Synthetic Route 10

Aripiprazole Lauroxil route010

Synthetic reference

Ponnaiah, Ravi; Kumar, Neela Praveen; Guruswamy, Batthini; Pendem, Krishnaiah; Lakkadasu, Satya Nagendra Kumar; Gattikoppula, Mahesh. Improved process for the preparation of aripiprazole lauroxil. Assignee Neuland Pharma Research Private Limited, India. WO 2018109775. 2018.